Last checked at Genedrive Shares Soar As It Says It Will Develop SARS-COV-2 Tests
Genedrive Shares Soar As It Says It Will Develop SARS-COV-2 Tests
25 Mar 20 14:57
- Home
- Share Prices
- NEX Exchange Share Prices
- Share Chat
- FX
- News
- Blogs
- RNS
- Media
- Trading
- Finance Tools
- Members
Latest Share Chat
Genedrive Share News (GDR)
GDR Share
Price
GDR Share
News
GDR Share
Chat6
GDR Share
Trades
GDR
Live RNS
GDR Share
Charts
GDR Level 2
Console
GDR Live
Share Price
GDR Broker
Ratings
GDR Directors
Deals
GDR Financial
Diary
GDR
Fundamentals
GDR Short
Positions
GDR
Media
GDR Information
Share Price Information for Genedrive (GDR)
Share Price is delayed by 15 minutes
Get Live Data
Share Price:
40.00
Bid:
39.00
Ask:
41.00
Change:
0.00
(0.00%)
Spread:
2.00 (5.13%)
Open:
31.00
High:
41.9999
Low:
28.0376
Yest. Close:
40.00
Last checked at -
Watchlists are a member only feature
Login to your account
Don't have an account? Click here to register.25 Mar 20 14:57Genedrive Shares Plunge 45% As Loss Widens On Shipping Order Delays
Genedrive Shares Plunge 45% As Loss Widens On Shipping Order Delays
4 Feb 20 12:22UK Earnings, Trading Statements Calendar - Next 7 Days
UK Earnings, Trading Statements Calendar - Next 7 Days
28 Jan 20 16:06Genedrive Antibiotic Induced Hearing Loss Test Kit Shows High Accuracy
Genedrive Antibiotic Induced Hearing Loss Test Kit Shows High Accuracy
3 Dec 19 10:10Genedrive upbeat on latest results from RNR1 kit testing
(Sharecast News) - Near-patient molecular diagnostics company Genedrive announced on Tuesday that in its case-control clinical validation, the antibiotic-induced hearing loss assay - the 'Genedrive MT-RNR1 ID' kit - achieved a diagnostic sensitivity of 100% and specificity of 100% on a cohort of 303 samples.
3 Dec 19 09:39Genedrive infant hearing loss test gets CE mark
(Sharecast News) - Molecular diagnostics company Genedrive announced on Monday that its antibiotic-induced hearing loss test, the 'Genedrive MT-RNR1 ID' kit, has obtained CE marking.
18 Nov 19 16:00Genedrive's Antibiotic Induced Hearing Loss Assay Receives CE Marking
Genedrive's Antibiotic Induced Hearing Loss Assay Receives CE Marking
18 Nov 19 11:15NHS Ethics Approval Granted For Genedrive MT-RNR1 Screening Test Trial
NHS Ethics Approval Granted For Genedrive MT-RNR1 Screening Test Trial
7 Oct 19 11:59Genedrive Outlook Positive As Revenue Up And Loss Narrows In Full Year
Genedrive Outlook Positive As Revenue Up And Loss Narrows In Full Year
3 Oct 19 11:00Genedrive loss narrowed after double-digit revenue rise
(Sharecast News) - Genedrive on Thursday reported a narrowed annual loss as revenues jumped as its commercial relationship with the US department of defense (DoD) exceeded expectations.
3 Oct 19 10:41Genedrive Revenue To Suffer On Lower Uptake Of Hepatitis Test Kits
(Alliance News) - Shares in Genedrive PLC fell Tuesday after the company warned that it will miss market expectations for 2020 financial year revenue due to slower than expected uptake of the HCV
9 Jul 19 10:54Genedrive Interim Loss Narrows As It Continues Focus On Hepatitis
LONDON (Alliance News) - Genedrive PLC on Thursday reported a reduction in its interim loss, as it continues to progress its hepatitis testing product.For the six months to the end of 2018,
28 Mar 19 10:36Genedrive losses narrow despite increased R&D costs
(Sharecast News) - Molecular diagnostics company Genedrive saw revenues tick ahead slightly in the first half of its financial year but increased research and development costs kept the firm in the red.
28 Mar 19 07:59Genedrive Interim Revenue Rises On US And UK Government Contracts
LONDON (Alliance News) - Genedrive PLC said Tuesday it increased its first-half income and made "good progress" on two UK government funded projects.For the six months to the end
15 Jan 19 12:44Genedrive makes progress with HCV kit in first half
(Sharecast News) - Near-patient molecular diagnostics company Genedrive issued an unaudited update for the six months ended 31 December on Tuesday, reporting revenue of £1.5m, up from £1.3m year-on-year.
15 Jan 19 10:17